BEAM
Price
$17.41
Change
+$0.16 (+0.93%)
Updated
May 9 closing price
Capitalization
1.73B
94 days until earnings call
XERS
Price
$5.01
Change
-$0.15 (-2.91%)
Updated
May 9 closing price
Capitalization
806.94M
88 days until earnings call
Ad is loading...

BEAM vs XERS

Header iconBEAM vs XERS Comparison
Open Charts BEAM vs XERSBanner chart's image
Beam Therapeutics
Price$17.41
Change+$0.16 (+0.93%)
Volume$2.38M
Capitalization1.73B
Xeris Biopharma Holdings
Price$5.01
Change-$0.15 (-2.91%)
Volume$2.55M
Capitalization806.94M
BEAM vs XERS Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. XERS commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and XERS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (BEAM: $17.41 vs. XERS: $5.01)
Brand notoriety: BEAM and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 90% vs. XERS: 71%
Market capitalization -- BEAM: $1.73B vs. XERS: $806.94M
BEAM [@Biotechnology] is valued at $1.73B. XERS’s [@Biotechnology] market capitalization is $806.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and XERS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while XERS’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • XERS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, XERS is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -13.98% price change this week, while XERS (@Biotechnology) price change was +6.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

XERS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.74B) has a higher market cap than XERS($807M). XERS YTD gains are higher at: 47.788 vs. BEAM (-29.798). XERS has higher annual earnings (EBITDA): -13.99M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. XERS (71.6M). BEAM has less debt than XERS: BEAM (161M) vs XERS (271M). XERS has higher revenues than BEAM: XERS (203M) vs BEAM (63.5M).
BEAMXERSBEAM / XERS
Capitalization1.74B807M215%
EBITDA-383.98M-13.99M2,744%
Gain YTD-29.79847.788-62%
P/E RatioN/AN/A-
Revenue63.5M203M31%
Total Cash851M71.6M1,189%
Total Debt161M271M59%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMXERS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBFAX37.660.06
+0.16%
American Funds Global Balanced 529A
APDLX14.500.01
+0.07%
Artisan Value Advisor
ETHSX12.62N/A
N/A
Eaton Vance Worldwide Health Sci A
NDVVX16.97N/A
N/A
MFS New Discovery Value R6
GLNAX23.07N/A
N/A
MFS Global New Discovery A